Netlist (NLST) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Company overview and business model
Provides high-performance memory solutions for enterprise customers across diverse industries, focusing on innovative products like LRDIMM and NVDIMM that address data bottleneck and retention challenges in high-performance computing.
Holds a robust portfolio of over 100 issued and pending U.S. and foreign patents in high bandwidth memory, hybrid memory, storage class memory, and related technologies.
Monetizes intellectual property through product sales, licensing, royalties, and enforcement actions against infringers, aiming to expand and defend its patent portfolio.
Use of proceeds and capital allocation
Net proceeds are expected to be used for general corporate purposes, including working capital and administrative expenses.
May allocate funds for acquisitions of complementary products, technologies, or businesses, though no specific plans or commitments exist.
Management retains broad discretion over the use of proceeds, with investments in interest-bearing, investment-grade securities until deployment.
Risk factors and disclosures
Investment involves a high degree of risk, with risks detailed in the prospectus supplement and incorporated SEC filings, including annual and quarterly reports.
Risks could adversely affect business, operating results, financial condition, access to capital, and future growth prospects.
Additional, currently unknown or immaterial risks may also impact operations and financial position.
Latest events from Netlist
- Q4 revenue soared 121% year-over-year as AI demand and memory shortages drove sharp price gains.NLST
Q4 20253 Mar 2026 - Q3 sales up 5% to $42.2M, net loss narrowed, but litigation and supply risks persist.NLST
Q3 20253 Feb 2026 - Q2 sales up 267% to $36.8M, $750M in legal wins, but losses and collection risks persist.NLST
Q2 20242 Feb 2026 - Q3 sales up 140% to $40.2M, net loss narrows, and major patent awards boost liquidity.NLST
Q3 202418 Jan 2026 - Revenue surged 113% in 2024, but losses and litigation risks remain high.NLST
Q4 202424 Dec 2025 - Up to $31 million in common stock may be sold to Lincoln Park Capital, with broad use of proceeds.NLST
Registration Filing16 Dec 2025 - Offering 11M+ shares via warrant exercise at $3.20/share, with proceeds for general corporate use.NLST
Registration Filing16 Dec 2025 - Shareholders to vote on re-electing three directors and updated disclosures on ownership and transactions.NLST
Proxy Filing1 Dec 2025 - Annual Meeting to elect sole director and ratify new auditor, with all oversight by the sole director.NLST
Proxy Filing1 Dec 2025